NCT00865670View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Infection
Interventions
DRUG

Azithromycin Monohydrate 600 mg Tablets

DRUG

Zithromax (azithromycin dihydrate) 600 mg Tablets

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00865670 - To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter